Rice, MD Anderson study highlights potential of mitochondria-targeted chemotherapies
Researchers from Rice University and the University of Texas MD Anderson Cancer Center have identified prospective new medications that cooperate with currently available medications to strike leukaemia head-on with a lethal one-two punch. Even while the possible medications won't be tested on cancer patients for years, a recent study in the journal Leukemia shows their promise and the creative approaches that helped lead to their discovery. For more info, Visit Current Science Daily!












